Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
Author
Department/s
Publishing year
2009
Language
English
Pages
325-326
Publication/Series
Blood
Volume
114
Issue
22
Document type
Conference paper: abstract
Publisher
American Society of Hematology
Topic
- Hematology
Conference name
51st Annual Meeting of the American-Society-of-Hematology
Conference date
2009-12-05 - 2009-12-08
Status
Published
ISBN/ISSN/Other
- ISSN: 1528-0020